Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa and Pomalidomide in R/R PCNSL
NCT05931328Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2024
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, pomalidomide in primary central nervous system lymphoma (PCNSL), sponsored by Jiangsu Provincial People's Hospital. Started Oct 2022; status: recruiting.
02
Drugs
thiotepapomalidomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT05931328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05931328.